Background Coronaviruses (CoVs) are distributed worldwide and have various susceptible hosts; CoVs infecting humans are called human coronaviruses (HCoVs). Although HCoV-specific drugs are still lacking, many potent targets for drug discovery are being explored, and many vigorously designed clinical trials are being carried out in an orderly manner. The aim of this review was to gain a comprehensive understanding of the current status of drug development against HCoVs, particularly severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Main text A scoping review was conducted by electronically searching research studies, reviews, and clinical trials in PubMed and the CNKI. Studies on HCoVs and therapeutic drug discovery published between January 2000 and October 2020 and in English or Chinese were included, and the information was summarized. Of the 3248 studies identified, 159 publication were finally included. Advances in drug development against HCoV, especially SARS-CoV-2, are summarized under three categories: antiviral drugs aimed at inhibiting the HCoV proliferation process, drugs acting on the host's immune system, and drugs derived from plants with potent activity. Furthermore, clinical trials of drugs targeting SARS-CoV-2 are summarized. Conclusions During the spread of COVID-19 outbreak, great efforts have been made in therapeutic drug discovery against the virus, although the pharmacological effects and adverse reactions of some drugs under study are still unclear. However, well-designed high-quality studies are needed to further study the effectiveness and safety of these potential drugs so as to provide valid recommendations for better control of the COVID-19 pandemic.

Objective: Foodborne parasitic diseases, although with a declining overall incidence rate, are still endangering local public safety. This review aims to describe the current situation and epidemiological trends of foodborne parasitic diseases in China in order to explore possible reasons contributors to its high prevalence in some areas, and propose strategies for prevention and control accordingly. Methods: A scoping review was conducted by searching PubMed, CNKI, Wanfang, CQVIP, Embase, and the Cochrane Library using search formula “foodborne parasitic diseases (or foodborne parasites)” AND “China”. Studies on foodborne parasitic diseases in China were considered, but only articles in English or Chinese published between January 1980 and June 2020 were retrieved. Included studies were screened according to the eligibility criteria: 1) diseases consistent with the WHO definition of foodborne parasitic diseases; 2) the food carriers were included in the WHO food classification; 3) data related to epidemiology, pathogenicity, and prevention and control; 4) Foodborne parasitic diseases cases or outbreaks in China. Results: A total of 111 out of 665 records were included and summarized. The prevalence of clonorchiasis, angiostrongyliasis, echinococcosis, trichinellosis and cysticercosis was still increasing although the infection rate of soil-transmitted nematodes has substantially decreased in recent years. Diverse eating habits, close contact with animals, and urbanization were contributing factors to the increase. Conclusions: Foodborne parasitic diseases remain an important public health issue in China with the progress of economic globalization and food diversification. We should manage to raise public awareness about the prevention and control of foodborne parasitic diseases, improve health and safety inspections, as well as public health practice.